Intellectual property

UK-based Darwinex Increases its Seed Allocation Programme to €120 Million

Retrieved on: 
Monday, December 20, 2021
FCA, Interactive Brokers, Intellectual property, Metric, Darwinia, Darwin Technologies, FRN, Challenger, CEO, Futures, Achievement, ETF, Financial technology, Seed, Retail

Investors access liquid strategies based on major Futures, US Equities and global ETFs on a one-stop-shop, regulated marketplace

Key Points: 
  • Investors access liquid strategies based on major Futures, US Equities and global ETFs on a one-stop-shop, regulated marketplace
    FCA (UK) regulated FinTech Darwinex, has increased its competitive seed allocation programme .
  • The programme - named DarwinIA Challenge - seeds the most investable providers on its marketplace for a notional of 120M.
  • The new format motivates strategy providers with innovative features, such as achievement awards and badges.
  • Check out this video for an overview of all new features in the DarwinIA Seed Allocation Programme.

DGAP-News: FIRST HYDROGEN PARTNERS WITH FEV CONSULTING GMBH FOR DEVELOPMENT OF HYDROGEN MOBILITY REFUELING STATIONS

Retrieved on: 
Monday, December 20, 2021
Hydrogen, Forward-looking statement, Intellectual property, Industry, Public expenditure, DGAP, THE, News, Marketing, Goal, THIS, Patent, TSX, Risk management, Cryptocurrency, COVID-19, First Hydrogen Corp., FEV Consulting GmbH, FIRST HYDROGEN CORP., FEV CONSULTING GMBH

Cautionary Note Regarding Forward-Looking Statements This news release contains information or statements that constitute "forward-looking statements."

Key Points: 
  • Cautionary Note Regarding Forward-Looking Statements This news release contains information or statements that constitute "forward-looking statements."
  • Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date.
  • First Hydrogen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.
  • The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

DGAP-News: UK-based Darwinex Increases its Seed Allocation Programme to €120 Million

Retrieved on: 
Monday, December 20, 2021
FCA, Interactive Brokers, Intellectual property, Metric, Darwinia, Darwin Technologies, FRN, Challenger, CEO, Futures, Achievement, ETF, Financial technology, Seed, Security (finance), Retail

Investors access liquid strategies based on major Futures, US Equities and global ETFs on a one-stop-shop, regulated marketplace

Key Points: 
  • Investors access liquid strategies based on major Futures, US Equities and global ETFs on a one-stop-shop, regulated marketplace
    FCA (UK) regulated FinTech Darwinex, has increased its competitive seed allocation programme .
  • The programme - named DarwinIA Challenge - seeds the most investable providers on its marketplace for a notional of 120M.
  • Check out this video for an overview of all new features in the DarwinIA Seed Allocation Programme.
  • Founded in 2012, Darwinex employs over 60 IT and financial engineers across its London and Madrid teams.

DGAP-News: APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-European intellectual property rights

Retrieved on: 
Monday, December 20, 2021
Ticker, China Biologic Products, Monheim am Rhein, Hypertension, Company, Hyperlipidemia, Device, Physician, Degenerative disease, Intellectual property, START, EU, CEO, Marketing, Patient, CDMO, Big Finish Productions, IP, Partnership, Fortis Healthcare, Compliance, Fine chemical, Pharmaceutical industry, Pharma, Midas Pharma, APONTIS PHARMA, MIDAS PHARMA, APONTIS PHARMA

APONTIS PHARMA for the first time owns all Europe-wide rights (IP - Intellectual Property) to the preparation, medication, or Single Pill

Key Points: 
  • APONTIS PHARMA for the first time owns all Europe-wide rights (IP - Intellectual Property) to the preparation, medication, or Single Pill
    Monheim am Rhein, 14 December 2021.
  • Today the Single Pill Company announces a development partnership with the German company Midas Pharma.
  • For the first time, APONTIS PHARMA owns the EU-wide rights (IP - Intellectual Property) to the combined medication.
  • "The established, trusting partnership with Midas Pharma for Single Pill developments has so far exclusively covered the German market.

Nokia wins five-year 5G deal with Elisa Estonia as sole RAN vendor

Retrieved on: 
Monday, December 20, 2021
Elisa, CEO, Research, Bell Labs, Nokia, Partnership, Next Generation Mobile Networks, Intellectual property, Leadership, Technology, Mobile phone, Risk management, Network equipment

Espoo, Finland Nokia today announced that it has been selected by Elisa Estonia, a subsidiary of Elisa Finland, for a nationwide 5G RAN deployment as well as to replace the existing 4G infrastructure in a five-year deal.

Key Points: 
  • Espoo, Finland Nokia today announced that it has been selected by Elisa Estonia, a subsidiary of Elisa Finland, for a nationwide 5G RAN deployment as well as to replace the existing 4G infrastructure in a five-year deal.
  • Under the deal, Nokia will provide equipment from its latest ReefShark System on Chip-powered AirScale equipment portfolio covering Elisa's nationwide radio network across the country.
  • Nokia also maintains a long-standing partnership with Elisa Corporation and was selected as a nationwide supplier of 5G RAN last year supporting their efforts to digitize Finland and make it a leading global 5G market.
  • Tommi Uitto, President of Mobile Networks at Nokia, said: We are delighted to have been selected by Elisa Estonia in this deal and for their trust in our technology leadership.

ETC Awarded Contract to Be the New Electronic Toll Collection System Provider for Central Texas Regional Mobility Authority

Retrieved on: 
Friday, December 17, 2021
Online, Forward-looking statement, Software as a service, Central Texas Regional Mobility Authority, Solution, KPI-driven code analysis, US, Big data, ITS, ETC, Algorithm, I-45, OTCQX, Industry, AET, Environment, COVID-19, Intellectual property, Review, Perception, Risk, LLC, Transport, Machine learning, Disease, Intelligent transportation system, Quality of life, AIF, CTRMA, Collection, Coronavirus, GLOBE, Maintenance, TSX, Partnership, News, Technology, MOMS, Cryptocurrency, Medical device, Risk management, Central Texas, Mopac

The initial six-year term is valued at US$72,791,680, and the contract is subject to customary terms and conditions.

Key Points: 
  • The initial six-year term is valued at US$72,791,680, and the contract is subject to customary terms and conditions.
  • ETCs next-generation smart congestion management systems will improve mobility and alleviate traffic on busy Austin-area roads.
  • The Mobility Authority prides itself on delivering best-in-class service, and we are confident ETC will help us exceed those expectations.
  • The Central Texas Regional Mobility Authority is an independent government agency created in 2002 to improve mobility in Travis and Williamson Counties in Texas.

MSM Enters Into Agreement to Merge With RTE

Retrieved on: 
Friday, December 17, 2021
Universe, Forward-looking statement, Failure, Philippine Esports Organization, Electronic Arts, Ecosystem, Company, Communications and Entertainment Limited, Shrek, Cartoon Network, Sale, Industry, Apple, Corporations Act 2001, Acquisition, Time, Intellectual property, Gruppo Riva, Sony Pictures, App, Intention, Risk, Esports, DreamWorks Animation, Animation, Square Enix, Lionsgate, RTE, Xbox Game Studios, DreamWorks, Investment, IP, Capcom, MSM, Google Store, Partnership, Person, Bollywood, Compliance, Technology, ASX, Public relations, Bank, Security (finance), Audit, Video game, Megastar, Konami

The Company has also agreed to issue the following securities:

Key Points: 
  • The Company has also agreed to issue the following securities:
    (i) 37,035,714 MSM Shares and 75,000,000 MSM Options as an advisory/management fee for the Capital Raise;
    (ii) 26,482,979 MSM Shares to advisers of RTE in satisfaction of fees payable by RTE in respect of a previous capital raise;
    (iii) 26,250,000 MSM Options and 26,250,000 options to acquire MSM Shares exercisable at $0.05 on or before 3 years from the date of issue to the advisory board of MSM; and
    (iv) 12,500,000 MSM Options to the board of directors of MSM, subject to compliance with the Corporations Act.
  • The Company is also considering pursuing a listing on another securities exchange after the RTE merger transaction and capital raising are completed.
  • RTE is now exceptionally well-positioned to take advantage of the fantastic growth opportunity in the global gaming and eSports ecosystem, which is attracting massive user and audience engagement.
  • MSM Corporation International Limited ("MSMCI") is an online entertainment company that specialises in building and launching new digital entertainment products.

Wireless Telecom Group, Inc. Announces the Sale of its RF Components Business, Microlab LLC, to RF Industries, Inc.

Retrieved on: 
Friday, December 17, 2021
Forward-looking statement, U.S. Securities and Exchange Commission, RF, Solution, Intellectual property, Company, Securities Exchange Act of 1934, Securities Act of 1933, Growth, NYSE, Sale, COVID-19, Information technology, Annual report, WTT, THE, NASDAQ, GPS, Autocar Sales and Service Building, Vista, SEC, Review, Radio, DLA, CEO, Investment, Security, LTE, GLOBE, Piper, Capital Group Companies, DLA Piper, Mobile phone, Risk management, Financial adviser, Sheila Holzworth, Microlab

Parsippany, New Jersey, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Wireless Telecom Group, Inc. (NYSE American: WTT) (the “Company”) today announced that it entered into a definitive agreement to sell its Microlab LLC radio frequency components business to RF Industries, Inc. (NASDAQ: RFIL) for an aggregate cash consideration of $24.25 million. The transaction, which was unanimously approved by the board of directors of both companies, is subject to various terms and conditions, including approval by Wireless Telecom Group’s shareholders. The Company will file a proxy statement regarding the proposed transaction with the Security and Exchange Commission (the “SEC”) as described below.

Key Points: 
  • Todays announcement accelerates Wireless Telecom Groups transformation into a leading test and measurement, and specialized 5G software service solutions provider.
  • Craig-Hallum Capital Group LLC is serving as exclusive financial advisors to Wireless Telecom Group and Bryan Cave Leighton Paisner LLP is acting as legal advisor.
  • Wireless Telecom Group, Inc., comprised of Boonton , CommAgility , Holzworth , Microlab and Noisecom , is a global designer and manufacturer of advanced RF and microwave components, modules, systems, and instruments.
  • Serving the wireless, telecommunication, satellite, military, aerospace, semiconductor and medical industries, Wireless Telecom Group products enable innovation across a wide range of traditional and emerging wireless technologies.

CMC Materials Wins Favorable ITC Final Determination Finding a Violation By DuPont and Issuing Order Excluding DuPont’s Infringing CMP Slurries from U.S.

Retrieved on: 
Friday, December 17, 2021
Aurora, U.S. Securities and Exchange Commission, CMC, Intellectual property, Growth, Sale, Nasdaq, United, Acquisition, Annual report, Review, U.S. Customs and Border Protection, Risk, General officer, Communication, General counsel, Marketing, ITC, United States International Trade Commission, Pandemic, Security (finance), Patent, Investment, GLOBE, CMP, Lists of disasters, Compliance, Technology, Health, DuPont, Risk management

Based on the Final Determination, the ITC issued an exclusion order and cease and desist orders prohibiting DuPonts importation, marketing, and sale of infringing products and components thereof in the United States.

Key Points: 
  • Based on the Final Determination, the ITC issued an exclusion order and cease and desist orders prohibiting DuPonts importation, marketing, and sale of infringing products and components thereof in the United States.
  • The ITC ordered DuPont to post a bond of 100 percent of the entered value of the infringing products imported or sold during the 60-day review period.
  • CMC Materials, Inc., headquartered in Aurora, Illinois, is a leading global supplier of consumable materials primarily to semiconductor manufacturers.
  • For more information about CMC Materials, Inc., visit www.cmcmaterials.com , or contact Colleen Mumford, Vice President, Communications and Marketing, at 630-499-2600.

Aquestive Therapeutics Added to NASDAQ Biotechnology Index

Retrieved on: 
Friday, December 17, 2021
Weather, Therapy, Intellectual property, Population, NASDAQ Biotechnology Index, NASDAQ, Risk, Legislation, Securities & Exchange Commission of Pakistan, Diazepam, Compliance, Rain, FDA, Seizure, Epilepsy, Growth, Incidence, Clobazam, Safety, Tongue, Drug development, GLOBE, Anaphylaxis, U.S. Securities and Exchange Commission, Adrenaline, Health, Degenerative disease, Nasdaq, Sunlight, COVID-19, Biotechnology, Marketing, Patent, NBI, Failure, Food, Health Canada, Buccal, Company, New Drug Application, CNS, Private Securities Litigation Reform Act, Sale, Industry, Annual report, IShares, Regulation of tobacco by the U.S. Food and Drug Administration, Patient, Cheek, Central nervous system, Technology, Pharmaceutical industry, Fine chemical, Index

WARREN, N.J., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients unmet needs and solve therapeutic problems, today announced that NASDAQ has added the company to the NASDAQ Biotechnology Index (Nasdaq: NBI) effective December 20, 2021.

Key Points: 
  • WARREN, N.J., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients unmet needs and solve therapeutic problems, today announced that NASDAQ has added the company to the NASDAQ Biotechnology Index (Nasdaq: NBI) effective December 20, 2021.
  • The NASDAQ Biotechnology Index is designed to track the performance of a set of biotechnology and pharmaceutical companies listed on The Nasdaq Stock Market (Nasdaq).
  • The Index is evaluated annually and serves as the basis for the iShares NASDAQ Biotechnology Index Fund (Nasdaq: IBB).
  • Because of this designation, shares of Aquestive Therapeutics will be included in the portfolios of NBI index funds.